NEW YORK, July 7, 2020 /PRNewswire/ --
If you own shares in any of the companies
listed above and
would like to discuss our investigations or have any questions
concerning
this notice or your rights or interests, please contact:
Joshua Rubin,
Esq.
WeissLaw LLP
1500 Broadway, 16th Floor
New York, NY 10036
(212) 682-3025
(888) 593-4771
stockinfo@weisslawllp.com
Rexahn Pharmaceuticals, Inc. (NASDAQ: REXN)
WeissLaw LLP is investigating possible breaches of fiduciary
duty and other violations of law by the board of directors of
Rexahn Pharmaceuticals, Inc. (NASDAQ: REXN) in
connection with the proposed stock-for-stock merger of the company
with privately-held Ocuphire Pharma, Inc. ("Ocuphire"). Under
the terms of the acquisition agreement, REXN will be issued
contingent value rights ("CVR") representing the right to receive
(i) 90% of payments received by the combined company pursuant to
its licensing agreements with BioSense Global LLC and Zhejiang
HaiChang Biotechnology Co., Ltd. during the 15-year period after
the closing of the merger; and (ii) 75% of the proceeds received by
the combined company from the monetization of REXN existing
intellectual property during the 10-year period after the
merger's close. Upon consummation of the proposed merger,
Ocuphire will own at least 85.7% of the newly-combined company,
with REXN stockholders owning the remaining 14.3%. If you own
REXN shares and wish to discuss this investigation or your rights,
please call us at one of the numbers listed above or visit our
website: http://www.weisslawllp.com/rexahn-pharmaceuticals-inc/
Delmarva Bancshares, Inc. (OTC: DLMV)
WeissLaw LLP is investigating possible breaches of fiduciary
duty and other violations of law by the board of directors of
Delmarva Bancshares, Inc. (OTC: DLMV) in connection
with the proposed acquisition of the company by BV Financial
Inc. Under the terms of the agreement, DLMV shareholders will
be entitled to receive $8.90 in cash
for each share of DLMV common stock that they own. If you own
DLMV shares and wish to discuss this investigation or your rights,
please call us at one of the numbers listed above or visit our
website: http://www.weisslawllp.com/delmarva-bancshares-inc/
View original content to download
multimedia:http://www.prnewswire.com/news-releases/shareholder-alert-weisslaw-llp-reminds-rexn-and-dlmv-shareholders-about-its-ongoing-investigations-301089643.html
SOURCE WeissLaw LLP